Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Mar;17(3):235-9.
doi: 10.1007/s12603-012-0394-4.

Gait variability at fast-pace walking speed: a biomarker of mild cognitive impairment?

O Beauchet  1 , G Allali, C Launay, F R Herrmann, C Annweiler
Affiliations
Comparative Study

Gait variability at fast-pace walking speed: a biomarker of mild cognitive impairment?

O Beauchet et al. J Nutr Health Aging. 2013 Mar.

Abstract

Background: The interpretation of the increase in stride-to-stride variability of stride time (STV) regarding the evolution of cognitive deficits across the dementia spectrum is matter of debate.

Objective: The aim of this study was to compare STV at usual and fast-pace walking speeds of MCI patients with that of cognitively healthy individuals (CHI) and Alzheimer's disease (AD) patients with mild dementia, while considering the effects of potential confounders.

Methods: STV while walking at usual and fast-pace walking speeds was recorded with the GAITRite® system from 116 older adults (mean age 75.6±6.5 years; 55.2% female) divided into 3 groups according to their cognitive status (44 CHI, 39 MCI patients and 33 AD patients with mild dementia).

Results: The full adjusted multiple linear regression models showed that high STV was associated with slow gait speed at usual-pace walking speed (P=0.002) and with the MCI status at fast-pace walking speed (P=0.015).

Conclusions: High STV at fast-pace walking speed was a specific gait disturbance of MCI patients in the sample of studied participants, and thus could be used in the future as a specific biomarker of MCI patients.

PubMed Disclaimer

References

    1. Beauchet O., Allali G., Berrut G., Hommet C., Dubost V., Assal F. Gait analysis in demented participants: Interests and perspectives. Neuropsychiatr Dis Treat. 2008;4:155–160. 10.2147/NDT.S2070 PubMed PMID: 18728766. - DOI - PMC - PubMed
    1. Verghese J., Wang C., Lipton R.B., Holtzer R., Xue X. Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry. 2007;78:929–935. 10.1136/jnnp.2006.106914 PubMed PMID: 17237140. - DOI - PMC - PubMed
    1. Verghese J., Robbins M., Holtzer R., Zimmerman M., Wang C., Xue X. Gait dysfunction in mild cognitive impairment syndromes. J Am Geriatr Soc. 2008;56:1244–1251. 10.1111/j.1532-5415.2008.01758.x PubMed PMID: 18482293. - DOI - PMC - PubMed
    1. Goldman W.P., Baty J.D., Buckles V.D., Sahrmann S., Morris J.C. Motor dysfunction in mildly demented AD individuals without extrapyramidal signs. Neurology. 1999;53:956–962. 10.1212/WNL.53.5.956 PubMed PMID: 10496252. - DOI - PubMed
    1. Kluger A., Gianutsos J.G., Golomb J., Ferris S.H., George A.E., Franssen E. Patterns of motor impairement in normal aging, mild cognitive decline, and early Alzheimer’s disease. J Gerontol B Psychol Sci Soc Sci. 1997;52:P28–P39. 10.1093/geronb/52B.1.P28 PubMed PMID: 9008673. - DOI - PubMed

Publication types